北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study
作者: Zhu, JR1; Bai, J1; Cai, NS1; Tang, B1; Fan, WH1; Guo, JZ1; Ke, YN1; Guo, JX1; Sheng, LH1; Lu, ZY1; Cheng, NN1
关键词: telmisartan ; losartan ; angiotensin II receptor blocker ; antihypertensives ; hypertension
刊名: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
发表日期: 2004-12-01
卷: suppl.145, 页:46-49
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal ; Pharmacology & Pharmacy
研究领域[WOS]: General & Internal Medicine ; Pharmacology & Pharmacy
关键词[WOS]: II RECEPTOR BLOCKERS ; CARDIOVASCULAR EVENTS ; DOSE-RESPONSE ; CHINA ; ANTAGONIST
英文摘要:

This multicentre, randomised, double-blind, double-dummy, parallel-group study compared the efficacy and safety of telmisartan with those of losartan after 8 weeks′ treatment. In total, 330 patients with mild-to-moderate hypertension (systolic blood pressure [SBP] <180 mmHg; diastolic blood pressure [DBP] 95-109 mmHg) were randomly assigned to receive once-daily treatment with telmisartan 40 mg (n = 164) or losartan 50 mg (n = 166). After 4 weeks′ treatment, if a patient′s DBP was greater than or equal to90 mmHg, the dose was increased to telmisartan 80 mg or losartan 100 mg, respectively. The results show that mean trough seated blood pressure was reduced significantly more in the telmisartan group than that in the losartan group (SBP 12.5 mmHg vs. 9.4 mmHg, p = 0.037; DBP 10.9 mmHg vs. 9.3 mmHg, p = 0.030). The overall DBP response rate (reduction from baseline in mean seated DBP greater than or equal to 10 mmHg and/or a mean seated DBP <90 mmHg) at the end of the study in the telmisartan group was higher than that in losartan group (70.1% vs. 58.7%, p = 0.020). At both the low and high doses, the DBP response rates for telmisartan were significantly higher than those for losartan (telmisartan 40 mg vs. losartan 50 mg: 46.3% vs. 32.5%, p = 0.010; telmisartan 80 mg vs. losartan 100 mg: 79.3% vs. 65.3%, p = 0.008). Adverse events with the two treatments were comparable (telmisartan vs. losartan 23.2% vs. 22.9%, p = 0.952). Most events were mild in intensity and abated within 72 h. Thus, telmisartan 40 mg or 80 mg administered once daily can reduce SBP and DBP effectively and safely.

语种: 英语
WOS记录号: WOS:000225945300009
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/49909
Appears in Collections:北京大学第三临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Fu Dan Univ, Zhong Shan Hosp, Dept Med, Shanghai 200032, Peoples R China
2.Fu Dan Univ, Huashan Hosp, Shanghai, Peoples R China
3.Shanghai Med Univ 2, Ruijin Hosp, Shanghai, Peoples R China
4.Sino Japan Friendship Hosp, Beijing, Peoples R China
5.Beijing Univ, Affiliated Hosp 3, Beijing 100871, Peoples R China
6.Friendship Hosp, Beijing, Peoples R China
7.Cent China Univ Sci & Technol, Wuhan, Peoples R China
8.Fu Dan Univ, Dept Pharmacol, Shanghai, Peoples R China

Recommended Citation:
Zhu, JR,Bai, J,Cai, NS,et al. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE,2004,suppl.145:46-49.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhu, JR]'s Articles
[Bai, J]'s Articles
[Cai, NS]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhu, JR]‘s Articles
[Bai, J]‘s Articles
[Cai, NS]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace